Yokoi F, Dang MT, Zhang L, Dexter KM, Efimenko I, Krishnaswamy S, Villanueva M, Misztal CI, Gerard M, Lynch P, Li Y (2021)
Reversal of motor-skill transfer impairment by trihexyphenidyl and reduction of dorsolateral striatal cholinergic interneurons in Dyt1 GAG knock-in mice
IBRO Neurosci Rep 11: 1

Jaako K, Waniek A, Parik K, Klimaviciusa L, Aonurm-Helm A, Noortoots A, Anier K, Van Elzen R, Gerard M, Lambeir AM, Rossner S, Morawski M, Zharkovsky A (2016)
Prolyl endopeptidase is involved in the degradation of neural cell adhesion molecules in vitro
Journal of Cell Science 129: 3792

Klimaviciusa L, Jain RK, Jaako K, Van Elzen R, Gerard M, Van der Veken P, Lambeir AM, Zharkovsky A (2012)
In situ prolyl oligopeptidase activity assay in neural cell cultures
Journal of Neuroscience Methodsods 204: 104

Myohanen TT, Hannula MJ, Van Elzen R, Gerard M, Van der Veken P, Garcia-Horsman JA, Baekelandt V, Mannisto PT, Lambeir AM (2012)
A prolyl oligopeptidase inhibitor, KYP-2047, reduces alpha-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease
British Journal of Pharmacology 166: 1097

Van der Veken P, Fulop V, Rea D, Gerard M, Van Elzen R, Joossens J, Cheng JD, Baekelandt V, De Meester I, Lambeir AM, Augustyns K (2012)
P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy
Journal of Medicinal Chemistry 55: 9856

Brandt I, Gerard M, Sergeant K, Devreese B, Baekelandt V, Augustyns K, Scharpe S, Engelborghs Y, Lambeir AM (2008)
Prolyl oligopeptidase stimulates the aggregation of alpha-synuclein
Peptides 29: 1472